In contrast to previous reports showing poor survival of HER2-positive gastric cancer patients who underwent surgery, HER2-positive patients showed a non-significant trend towards a better outcome in this study (Allgayer et al, 2000; Tanner et al, 2005). The gene discussed is ERBB2; the disease is gastric cancer.